| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Chief Executive Officer, Director | Common Stock | 1,541,645 | $65,828,241 | $42.70 | 13 Jan 2026 | Direct |
| Allovir, Inc. | Director | Common Stock | 16,674,766 | $13,211,417 | $0.7923 | 06 Jun 2024 | Shares held by ElevateBio LLC |
| Scholar Rock Holding Corp | Chief Executive Officer, Director | Common Stock | 205,000 | $9,030,250 | $44.05 | 13 Jan 2026 | By trust |
| Allovir, Inc. | Director | Common Stock | 2,143,662 | $1,698,423 | $0.7923 | 06 Jun 2024 | Direct |
| Seer, Inc. | Director | Class A Common Stock | 355,128 | $721,727 | $2.03 | 12 Jun 2024 | Direct |
| Allovir, Inc. | Director | Common Stock | 720,965 | $571,221 | $0.7923 | 06 Jun 2024 | Shares held by The Hallal Family Irrevocable Trust 2012 |
| Allovir, Inc. | Director | Common Stock | 138,153 | $109,459 | $0.7923 | 06 Jun 2024 | Shares held by Terrie A. Hallal Family Irrevocable Trust 2012 |
| iTeos Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $10.24 | 06 Jun 2025 | Direct |
| Scholar Rock Holding Corp | Chief Executive Officer, Director | Stock Option (Right to Buy) | 275,167 | 02 May 2025 | Direct | ||
| Seer, Inc. | Director | Stock Option (right to buy) | 34,735 | 14 Jun 2023 | Direct | ||
| Kalaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 18,000 | 10 Apr 2025 | Direct | ||
| iTeos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 29 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 13 Jan 2026 | 1 | -$2,453,115 | 4 | Chief Executive Officer, Director | 15 Jan 2026, 19:54 |
| SRRK | Scholar Rock Holding Corp | 08 Oct 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 09 Oct 2025, 17:30 |
| ITOS | iTeos Therapeutics, Inc. | 29 Aug 2025 | 2 | $0 | 4 | Director | 29 Aug 2025, 16:30 |
| ITOS | iTeos Therapeutics, Inc. | 04 Jun 2025 | 9 | -$671,272 | 4 | Director | 06 Jun 2025, 21:03 |
| SRRK | Scholar Rock Holding Corp | 02 May 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 06 May 2025, 17:00 |
| SRRK | Scholar Rock Holding Corp | 27 Apr 2025 | 2 | $0 | 4 | CEO, Director | 29 Apr 2025, 18:07 |
| KLRS | Kalaris Therapeutics, Inc. | 10 Apr 2025 | 1 | $0 | 4 | Director | 11 Apr 2025, 16:41 |
| SRRK | Scholar Rock Holding Corp | 27 Jun 2024 | 2 | $0 | 4 | Director | 01 Jul 2024, 17:12 |
| SEER | Seer, Inc. | 12 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:19 |
| ITOS | iTeos Therapeutics, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 20:00 |
| KLRS | Allovir, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 07 Jun 2024, 16:05 |
| SRRK | Scholar Rock Holding Corp | 21 Jun 2023 | 1 | $0 | 4 | Director | 22 Jun 2023, 18:47 |
| SEER | Seer, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 21:16 |
| ITOS | iTeos Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 19:54 |
| KLRS | Allovir, Inc. | 11 May 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 12 May 2023, 17:00 |
| KLRS | Allovir, Inc. | 19 Oct 2022 | 1 | -$5,070,000 | 4 | Director, 10%+ Owner | 21 Oct 2022, 21:30 |
| KLRS | Allovir, Inc. | 29 Sep 2022 | 1 | -$2,940,920 | 4 | Director, 10%+ Owner | 30 Sep 2022, 16:05 |
| KLRS | Allovir, Inc. | 28 Jul 2022 | 1 | +$15,000,000 | 4 | Director, 10%+ Owner | 01 Aug 2022, 16:38 |
| KLRS | Allovir, Inc. | 21 Jul 2022 | 1 | -$22,528 | 4 | Director, 10%+ Owner | 21 Jul 2022, 19:13 |
| SRRK | Scholar Rock Holding Corp | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 17:01 |
| SEER | Seer, Inc. | 15 Jun 2022 | 2 | $0 | 4 | Director | 17 Jun 2022, 18:36 |
| ITOS | iTeos Therapeutics, Inc. | 08 Jun 2022 | 13 | -$487,173 | 4 | Director | 10 Jun 2022, 19:51 |
| KLRS | Allovir, Inc. | 03 Jun 2022 | 1 | -$241,106 | 4 | Director, 10%+ Owner | 06 Jun 2022, 16:05 |
| SRRK | Scholar Rock Holding Corp | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:34 |
| KLRS | Allovir, Inc. | 17 May 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 19 May 2022, 16:24 |
| KLRS | Allovir, Inc. | 21 Apr 2022 | 1 | -$24,812 | 4 | Director, 10%+ Owner | 22 Apr 2022, 08:31 |
| KLRS | Allovir, Inc. | 10 Mar 2022 | 2 | -$491,850 | 4 | Director, 10%+ Owner | 11 Mar 2022, 18:14 |
| KLRS | Allovir, Inc. | 24 Jan 2022 | 1 | -$136,889 | 4 | Director, 10%+ Owner | 25 Jan 2022, 15:15 |
| ITOS | iTeos Therapeutics, Inc. | 20 Dec 2021 | 5 | -$2,004,000 | 4 | Director | 22 Dec 2021, 18:59 |
| SEER | Seer, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 18:28 |
| ITOS | iTeos Therapeutics, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 21 Jun 2021, 20:13 |
| SRRK | Scholar Rock Holding Corp | 27 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 16:17 |
| KLRS | Allovir, Inc. | 25 May 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 27 May 2021, 16:54 |